Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
I missed that comment but there is an individual, who calls himself/herself Sangijuelas1 (Spanish for leeches), who is persistently commenting, with very limited "justification", that Synairgen has missed the boat as regards Covid-19. The latest in a long line of imbeciles, who waste space on bulletin boards for no apparent purpose.
Synairgen have a stack of research papers, compiled for well over a decade verifying the suitability of SNG001's potential in effectively treating a variety of respiratory diseases. I really wish that these moronic individuals could find better use for their time, although they are are more in the needy, attention seeking category than anything else.
An interesting piece of analysis there Divvyup. I am never 100% certain about the figures that emerge from simplywall.st. Only in the sense of whether the shares are owned by the Institutions themselves or whether the Institutions are holding them as an accumulation of retail investors shareholdings? The latter proved to be the case for another stock in which I am invested.
The indisputable fact is that the gross holdings have increased over time in all the institutions. A small positive indicator in my view.
What do mallards do if they dont understand a quack?
Consult a ducktionary
I am surprised that the share price is continuing at the current level, as I expected to see a slow steady rise this morning. My prediction of the post New Year share price movement was also incorrect. I would never have anticipated two substantially down days to 191p. I agree with the general opinion that there are still major buyers dictating the current share price action? None of us really knows, but it is a plausible theory. A forthcoming TR1 from Polygon or another II would confirm it and add further reassurance, to add to this week’s update from the company.
Thank you for those comments. It seems to be as I previously thought. We all imagined that the share price would be appreciably higher by now. The developments needed to bring it about have been delayed, and this company resides on investors’ watchlists until something precipitates a change.
I am content with having topped up substantially at a price considerably lower than today’s price. I also acted on the much appreciated comments volunteered on this board a few weeks ago by elevating the price on my sell order.
I own my decisions, but it is always good to listen to the views of others beforehand. That is the main function of an investment bulletin board as I see it. The usual DYOR etc advice should, however, predominate in any investment decision however big or small.
The key points from the Oct 7 placing RNS are:
* Trevor Brown, CEO of IQ-AI, has subscribed £150,000 for 3,000,000 Placing Shares in the Placing.
* Subscribers in the Placing have been issued with warrants to subscribe for a further 12,400,000 Ordinary Shares at a price of 7.5p per share, exercisable for 3 months.
Today is the 3 month deadline date. Surely any subscriber to the placement wishing to exercise their warrants today, would try to buy the maximum amount of shares at a discount to the 7.5p price beforehand?
I agree fully that given the potential of IB’s technology, 7.5p could well be cheap? However, what puzzles me is that there have been good opportunities in recent weeks and months to buy in at a lower price. Why then wait until the warrant deadline to buy stock? Unless, that is, there are other factors at work which I am not aware of?
I agree that there could well be an interesting day ahead, and I shall check again this afternoon in case there are developments.
He is an early riser. He gets up at the quack of dawn.
Sorry, a big mistake in my last post. I meant to say that the vast majority contributing to this board are in the "optimistic with some experience behind it" category. A major "slip" on my part for which I humbly apologise.
A former tutor often urged caution in all matters. One of his frequently offered phrases was "There's many a slip 'twixt the cup and the lip". As a Synairgen investor of nearly eighteen months, I believe that it is fair to say that we have encountered significant slippage on a number of occasions last year. Thankfully we are well through that phase.
Here is another phrase aimed at the individuals, who have persistently attempted to counter the positivity on this board this week. "Optimism with some experience behind it is much more energizing than plain old experience with a certain degree of cynicism." I believe that the majority here are in the latter category.
Finally back to the thread. My original sell target 18 months ago was 300p by the end of 2022. My expectations are now considerably higher, although I am planning to remain on board, and fully invested, and intend to monitor how the situation unfolds this year.
Ndn71.
I totally get your viewpoint on the information supplied by the company via twitter earlier today, followed by the usual understatement in Richard Marsden's tweet. However, I believe that most well-researched investors would interpret the message as a further positive sign? I am certain that the company would have issued nothing were it otherwise.
Regards and good wishes.
poorinvestor
Hope you are keeping well. Your take on this is well measured. My view of Alessandro Zamboni may well change once this investment takes off in a major way. Thankfully, there are not too many snakes on the ground here today. They will all slither away when the expected RNS bearing good news arrive.
Regards and with my best wishes.
Doctor100.
There is nothing to disagree with in your comments. It is all to do with the different impressions that we all form, given the same information. I am super confident that this investment will ultimately succeed. Then, I too may be lauding Alessandro Zamboni.
Regards, and good wishes.
Wigster 77. The google online dictionary defines "twitterati" as "avid or frequent users of the social media application twitter."
Regards and good wishes.
Axe-Capital. I found this definition.
Clitterati are women who consider themselves as literary intellectuals with a high awareness of their sexuality. Usually they are female novelists, ageing movie stars, wives of powerful statesmen, chat show hosts, chat show panellists.e.g. Germaine Greer, Hilary Clinton.
I daresay there are a few male equivants included in the all-embracing "twitterati".
With apologies if my lack of inclusivity in that comment has caused offence, but wokeness is not my strong suit.
This has evidently made most of us super confident about the P3 clinical trial outcome, and the route to market. What is surprising is that the get rich quick "twitterati" investors haven't caught on? Surely an investment in Synairgen at the current price has been further de-risked following the emergence of today's tweet?
Dumbpunter. I expect you have singlehandedly conspired to ruin many a good party in your time. It's not working here though. Why not go elsewhere where you are welcome?
https://www.youtube.com/watch?v=Ee3Jh5qRDMo
Thank you for sharing that information. The positivity in that simple message, accompanied by the slide show of 2021 headlines, continues to inspire confidence ahead of the forthcoming clinical trial outcome. The phrase "locked and loaded" quickly sprung to my mind.
Many genuine investors, with a sizeable investment in this company, continue to give the CEO more respect than he deserves. The concept upon which the success of this company rests is well worth an investment. The CEO's performance is not. He may well be a majority shareholder, but should consider standing down and placing a more credible figurehead in his place. His track record, notably under delivery on promised actions, surely should not be maintained for much longer? I daresay that when the financial targets begin to be realised, then all will be forgiven.
……. From Warren Buffet to those who have sold in a hurry this morning.
“Today people who hold cash equivalents feel comfortable. They shouldn’t. They have opted for a terrible long-term asset, one that pays virtually nothing and is certain to depreciate in value.”
I speak from hard earned experience. I have on several occasions sold share holdings for moderate profits. On a few occasions, days later, far greater profits were on offer for those particular stocks. I suspect that more than a few Synairgen investors are going to regret selling their stock by the end of the current Q1 period.
I would agree with that Fruitsnveg. Two of our good friends have practiced Buddhism on a daily basis for over 30 years. Recently both contracted Covid-19 while away on a short break. The initial symptoms were very debilitating, and they immediately resorted to a modified and extended version of their daily meditative routines, which involve repetitive chanting. They maintained this for one day. The following day, after a period of deep sleep, they had both substantially recovered. It took another five days to bring about what amounted to a full recovery. Both were doubly vaccinated (the maximum available dosage at the time), and had, as far as possible, followed the designated protocols. They immediately returned to work on arriving home, following 10 days of quarantine isolation and a negative test. Both have been on top of their game, with no residual symptoms, since then.
Earlier today, I read an article debating whether Omicron had peaked in London? Now it appears that another variant which spreads quickly has been detected.
Even as cases of Omicron, a Covid-19 "variant of concern" identified first in South Africa multiply quickly around the globe, another new Covid-19 variant is being reported from France which is believed to be much more infectious than Omicron. Scientists have named the new variant "IHU".
IHU or B.1.640.2 is reportedly a new Covid-18 variant discovered in France by researchers at the Institute IHU Mederranee Infection. According to reports, researchers have claimed that the new variant has 46 more mutations than Omicron, which had already spread like wildfire around the world. The findings, published in a paper, state, "Fourteen amino acid substitutions, including N501Y and E484K, and 9 deletions are located in the spike protein. This genotype pattern led to creating a new Pangolin lineage named B.1.640.2, which is a phylogenetic sister group to the old B.1.640 lineage renamed B.1.640.1".
The researchers further wrote, "These data are another example of the unpredictability of the emergence of SARS-CoV-2 variants, and of their introduction in a given geographical area from abroad."
The IHU variant was first discovered in France. As of now, 12 people in France have reportedly tested positive for the variant. The cases have all been detected near Marseilles have a travel history with the African nation of Cameroon.
The World Health Organisation has not commented on the new development yet, meaning that the new variant has not been identified and named by the global health body.